Insulin Price Cap Chances Wane in Senate as Year-End Approaches

The outlook for legislation to cap what millions of Americans pay for insulin is dimming as Congress nears the end of this session, lawmakers warned this week.

The Senate is set to be in session until Dec. 22 and congressional leaders are focused on funding the government, passing the annual defense authorization bill, and confirming a slew of judges. There may be no room left for an insulin bill, said Sen. Jeanne Shaheen (D-N.H.), who along with Sen. Susan Collins (R-Maine) introduced a bill to limit at $35 per month what people with private insurance pay for the crucial diabetes ...